Copyright Reports & Markets. All rights reserved.

Global Cobamamide for Injection Market Research Report 2021

Request for Sample of this report
Buy now

1 Cobamamide for Injection Market Overview

  • 1.1 Product Overview and Scope of Cobamamide for Injection
  • 1.2 Cobamamide for Injection Segment by Type
    • 1.2.1 Global Cobamamide for Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 0.5mg
    • 1.2.3 1.0mg
    • 1.2.4 1.5mg
  • 1.3 Cobamamide for Injection Segment by Application
    • 1.3.1 Cobamamide for Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Drug Store
    • 1.3.4 Other
  • 1.4 Global Cobamamide for Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Cobamamide for Injection Revenue 2016-2027
    • 1.4.2 Global Cobamamide for Injection Sales 2016-2027
    • 1.4.3 Cobamamide for Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Cobamamide for Injection Market Competition by Manufacturers

  • 2.1 Global Cobamamide for Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Cobamamide for Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Cobamamide for Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Cobamamide for Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Cobamamide for Injection Market Competitive Situation and Trends
    • 2.5.1 Cobamamide for Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Cobamamide for Injection Players Market Share by Revenue
    • 2.5.3 Global Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Cobamamide for Injection Retrospective Market Scenario by Region

  • 3.1 Global Cobamamide for Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Cobamamide for Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Cobamamide for Injection Market Facts & Figures by Country
    • 3.3.1 North America Cobamamide for Injection Sales by Country
    • 3.3.2 North America Cobamamide for Injection Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Cobamamide for Injection Market Facts & Figures by Country
    • 3.4.1 Europe Cobamamide for Injection Sales by Country
    • 3.4.2 Europe Cobamamide for Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Cobamamide for Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Cobamamide for Injection Sales by Region
    • 3.5.2 Asia Pacific Cobamamide for Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Cobamamide for Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Cobamamide for Injection Sales by Country
    • 3.6.2 Latin America Cobamamide for Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Cobamamide for Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Cobamamide for Injection Sales by Country
    • 3.7.2 Middle East and Africa Cobamamide for Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Cobamamide for Injection Historic Market Analysis by Type

  • 4.1 Global Cobamamide for Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Cobamamide for Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Cobamamide for Injection Price by Type (2016-2021)

5 Global Cobamamide for Injection Historic Market Analysis by Application

  • 5.1 Global Cobamamide for Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Cobamamide for Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Cobamamide for Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Haerbin Medisan
    • 6.1.1 Haerbin Medisan Corporation Information
    • 6.1.2 Haerbin Medisan Description and Business Overview
    • 6.1.3 Haerbin Medisan Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Haerbin Medisan Product Portfolio
    • 6.1.5 Haerbin Medisan Recent Developments/Updates
  • 6.2 North China Pharmaceutical Group
    • 6.2.1 North China Pharmaceutical Group Corporation Information
    • 6.2.2 North China Pharmaceutical Group Description and Business Overview
    • 6.2.3 North China Pharmaceutical Group Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 North China Pharmaceutical Group Product Portfolio
    • 6.2.5 North China Pharmaceutical Group Recent Developments/Updates
  • 6.3 Chongqing Yaoyou Pharmaceutical
    • 6.3.1 Chongqing Yaoyou Pharmaceutical Corporation Information
    • 6.3.2 Chongqing Yaoyou Pharmaceutical Description and Business Overview
    • 6.3.3 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Chongqing Yaoyou Pharmaceutical Product Portfolio
    • 6.3.5 Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
  • 6.4 Hainan Star Pharmaceutical
    • 6.4.1 Hainan Star Pharmaceutical Corporation Information
    • 6.4.2 Hainan Star Pharmaceutical Description and Business Overview
    • 6.4.3 Hainan Star Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Hainan Star Pharmaceutical Product Portfolio
    • 6.4.5 Hainan Star Pharmaceutical Recent Developments/Updates
  • 6.5 Hebei Zhitong Biopharmaceutical
    • 6.5.1 Hebei Zhitong Biopharmaceutical Corporation Information
    • 6.5.2 Hebei Zhitong Biopharmaceutical Description and Business Overview
    • 6.5.3 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Hebei Zhitong Biopharmaceutical Product Portfolio
    • 6.5.5 Hebei Zhitong Biopharmaceutical Recent Developments/Updates
  • 6.6 Jiangsu Jiuxu Pharmaceutical
    • 6.6.1 Jiangsu Jiuxu Pharmaceutical Corporation Information
    • 6.6.2 Jiangsu Jiuxu Pharmaceutical Description and Business Overview
    • 6.6.3 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Jiangsu Jiuxu Pharmaceutical Product Portfolio
    • 6.6.5 Jiangsu Jiuxu Pharmaceutical Recent Developments/Updates
  • 6.7 Jiuquan Dadeli pharmaceutical
    • 6.6.1 Jiuquan Dadeli pharmaceutical Corporation Information
    • 6.6.2 Jiuquan Dadeli pharmaceutical Description and Business Overview
    • 6.6.3 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Jiuquan Dadeli pharmaceutical Product Portfolio
    • 6.7.5 Jiuquan Dadeli pharmaceutical Recent Developments/Updates

7 Cobamamide for Injection Manufacturing Cost Analysis

  • 7.1 Cobamamide for Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Cobamamide for Injection
  • 7.4 Cobamamide for Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Cobamamide for Injection Distributors List
  • 8.3 Cobamamide for Injection Customers

9 Cobamamide for Injection Market Dynamics

  • 9.1 Cobamamide for Injection Industry Trends
  • 9.2 Cobamamide for Injection Growth Drivers
  • 9.3 Cobamamide for Injection Market Challenges
  • 9.4 Cobamamide for Injection Market Restraints

10 Global Market Forecast

  • 10.1 Cobamamide for Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Cobamamide for Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Cobamamide for Injection by Type (2022-2027)
  • 10.2 Cobamamide for Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Cobamamide for Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Cobamamide for Injection by Application (2022-2027)
  • 10.3 Cobamamide for Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Cobamamide for Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Cobamamide for Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    0.5mg
    1.0mg
    1.5mg

    Segment by Application
    Hospital
    Drug Store
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Haerbin Medisan
    North China Pharmaceutical Group
    Chongqing Yaoyou Pharmaceutical
    Hainan Star Pharmaceutical
    Hebei Zhitong Biopharmaceutical
    Jiangsu Jiuxu Pharmaceutical
    Jiuquan Dadeli pharmaceutical

    Buy now